Clinical Trials Logo

Laxity; Skin clinical trials

View clinical trials related to Laxity; Skin.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05249257 Completed - Cellulite Clinical Trials

Durability and Safety of CCH With Two Different Injection Techniques in Cellulite With Laxity

Start date: January 25, 2022
Phase:
Study type: Observational

All participants who completed the EN3835-224 study will be invited to participate in this observational study to evaluate long term durability of response and safety.

NCT ID: NCT04719013 Completed - Laxity; Skin Clinical Trials

Treatment With the Evoke System for Facial and Submental Laxity

Start date: December 1, 2020
Phase: N/A
Study type: Interventional

The aim of the study is to evaluate the efficacy, patient comfort, and patient satisfaction after Evoke treatment for face and submental area

NCT ID: NCT04580303 Completed - Cellulite Clinical Trials

CCH Treatment of Cellulite in the Presence of Dermal Laxity With Comparison Between Two (2) Different Injection Techniques

Start date: October 1, 2020
Phase: Phase 2
Study type: Interventional

This study is designed to investigate the safety and efficacy of collagenase clostridium histolyticum (CCH) for the treatment of mild to moderate edematous fibrosclerotic panniculopathy (cellulite) in participants with moderate to severe dermal laxity in the buttocks or thighs with comparison between two (2) different CCH injection techniques.

NCT ID: NCT03583918 Completed - Laxity; Skin Clinical Trials

Efficacy of Micro-excisional Skin Removal by Micro-coring Device in Treatment of Wrinkles and Laxity of Face and Neck

MCD
Start date: June 1, 2017
Phase: N/A
Study type: Interventional

This is a prospective, multi-center, pilot study evaluating effectiveness of micro-excisional skin remodeling by micro-coring skin in subjects meeting the Inclusion Criteria. Subjects will undergo bilateral treatment on the face and neck (upper and lower cheek, upper and lower lip, periocular and perioral areas, submandibular and middle neck, etc). The exact treatment area(s), choice of treatment density are left to the Investigator's discretion and subject's consent. Up to 3 treatments are allowed with a minimum of 30-day between the consecutive treatments.